This site uses cookes. By using this site you are consenting to their use according to our Cookie policy.

i agree

Gonçalo Bernardes' team, iMM Lisboa, has developed a technique that may reduce the toxicity to cancer therapies. By binding a monoclonal antibody to anti-cancer medication, therapies can be more efficiently targeted towards the tumors.



Correio da Manhã

TV Europa